advertisement
11.13.4 Betablocker and prostaglandin (33)
Showing records 1 to 25
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin80798 Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study
Bourne RRA
BMJ open 2019; 9: e024129
81286 Assessment of the optic nerve head, peripapillary, and macular microcirculation in the newly diagnosed patients with primary open-angle glaucoma treated with topical tafluprost and tafluprost/timolol fixed combination
Kurysheva NI
Taiwan journal of ophthalmology 2019; 9: 93-99
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Aptel F
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Aptel F
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Pfeiffer N
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Pfeiffer N
Journal of Glaucoma 2019; 0:
80798 Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study
Kaarniranta K
BMJ open 2019; 9: e024129
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Schmickler S
Journal of Glaucoma 2019; 0:
80798 Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study
Lorenz K
BMJ open 2019; 9: e024129
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Schmickler S; Clarke J
Journal of Glaucoma 2019; 28: 498-506
80798 Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study
Traverso CE
BMJ open 2019; 9: e024129
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Clarke J; Lavín-Dapena C
Journal of Glaucoma 2019; 0:
80798 Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study
Vuorinen J
BMJ open 2019; 9: e024129
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C; Lavín-Dapena C; Moreno-Montañés J
Journal of Glaucoma 2019; 28: 498-506
80798 Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study
Ropo A
BMJ open 2019; 9: e024129
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Moreno-Montañés J; Żarnowski T
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Żarnowski T
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Csutak A
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Csutak A
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Jugaste T; Jugaste T
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 0:
81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Volksone L
Journal of Glaucoma 2019; 28: 498-506
80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Volksone L; Astakhov YS
Journal of Glaucoma 2019; 0:
